Skip to Main Content

Author Details

Dimple Chakravarty
Icahn School of Medicine at Mount Sinai
2007
38
19
PMIDPaper TitleJournal TitlePublished Year
36484816When to order genomic tests: development and external validation of a model to predict high-risk prostate cancer at the genotypic level.World J Urol2023
37684128Genitourinary cancer neoadjuvant therapies: current and future approaches.Trends Cancer2023
36697832Author Correction: Analyses of non-coding somatic drivers in 2,658 cancer whole genomes.Nature2023
34621012Impact of diverticular disease on prostate cancer risk among hypertensive men.Prostate Cancer Prostatic Dis2022
35347282Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.Nat Med2022
35851878Author Correction: Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery.Nat Med2022
35681714Association between Incidental Pelvic Inflammation and Aggressive Prostate Cancer.Cancers (Basel)2022
35950923A First-in-Class Inhibitor of ER Coregulator PELP1 Targets ER+ Breast Cancer.Cancer Res2022
34798639Why do African-American men face higher risks for lethal prostate cancer?Curr Opin Urol2022
33067016Hood Technique for Robotic Radical Prostatectomy-Preserving Periurethral Anatomical Structures in the Space of Retzius and Sparing the Pouch of Douglas, Enabling Early Return of Continence Without Compromising Surgical Margin Rates.Eur Urol2021
33599076Racial disparity in prostate cancer in the African American population with actionable ideas and novel immunotherapies.Cancer Rep (Hoboken)2021
33915795Increased Hospitalization and Mortality from COVID-19 in Prostate Cancer Patients.Cancers (Basel)2021
34083737Comparative analysis of 1152 African-American and European-American men with prostate cancer identifies distinct genomic and immunological differences.Commun Biol2021
33008499Immunotherapy for Metastatic Prostate Cancer: Current and Emerging Treatment Options.Urol Clin North Am2020
34173542Impact of COVID-19 on Prostate Cancer Management: Guidelines for Urologists.Eur Urol Open Sci2020
33305659Clinical stage molecule PT150 is a modulator of glucocorticoid and androgen receptors with antiviral activity against SARS-CoV-2.Cell Cycle2020
32641750Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer.Commun Biol2020
28663546Inherited determinants of early recurrent somatic mutations in prostate cancer.Nat Commun2017
26781813Role of non-coding sequence variants in cancer.Nat Rev Genet2016
26181256Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.JAMA Oncol2015
25415230The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.Nat Commun2014
24092746Integrative annotation of variants from 1092 humans: application to cancer genomics.Science2013
22086908Significance of PELP1 in ER-negative breast cancer metastasis.Mol Cancer Res2012
22496589Identification of functionally active, low frequency copy number variants at 15q21.3 and 12q21.31 associated with prostate cancer risk.Proc Natl Acad Sci U S A2012
21184269Significance of ER-Src axis in hormonal therapy resistance.Breast Cancer Res Treat2011
21479260A computational framework discovers new copy number variants with functional importance.PLoS One2011
21421858Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.Clin Cancer Res2011
21196412Integrin-linked kinase 1: role in hormonal cancer progression.Front Biosci (Schol Ed)2011
19446313Steroid receptors, HER2/neu and Ki-67, in endometrioid type of endometrial carcinoma: Correlation with conventional histomorphological features of prognosis.Acta Histochem2010
20807815Cyclin-dependent kinase-mediated phosphorylation plays a critical role in the oncogenic functions of PELP1.Cancer Res2010
20448663PELP1 is a reader of histone H3 methylation that facilitates oestrogen receptor-alpha target gene activation by regulating lysine demethylase 1 specificity.EMBO Rep2010
20460518Extranuclear functions of ER impact invasive migration and metastasis by breast cancer cells.Cancer Res2010
20014005PELP1: A novel therapeutic target for hormonal cancers.IUBMB Life2010
19800002Regulation of aromatase induction by nuclear receptor coregulator PELP1.J Steroid Biochem Mol Biol2010
18559538Role of PELP1/MNAR signaling in ovarian tumorigenesis.Cancer Res2008
18931615Estrogen receptor beta (ERbeta) in endometrial simple hyperplasia and endometrioid carcinoma.Appl Immunohistochem Mol Morphol2008
18505929Growth factor regulation of estrogen receptor coregulator PELP1 functions via Protein Kinase A pathway.Mol Cancer Res2008
17309672Estrogen receptor beta1 and the beta2/betacx isoforms in nonneoplastic endometrium and in endometrioid carcinoma.Int J Gynecol Cancer2007
  • 1 - 38 of 38

Recommended Authors

Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 7
Yuliang Wang
The Chinese University of Hong Kong
Career Start Year 2014
Number of shared co-authors 0
Haiyang Guo
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 9
Sungyong You
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 12
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 1
Michael C Haffner
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 14
Robert H Bell
University of British Columbia
Career Start Year 2004
Number of shared co-authors 15
Wilbert Zwart
Oncode Institute, The Netherlands Cancer Institute
Career Start Year 2004
Number of shared co-authors 9
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 43
Luke A Selth
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 10
Tarek A Bismar
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 28
Ladan Fazli
University of British Columbia
Career Start Year 2002
Number of shared co-authors 21
Ilsa Coleman
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 19
Saravut J Weroha
Mayo Clinic
Career Start Year 2001
Number of shared co-authors 1
Michael Fraser
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2001
Number of shared co-authors 11
Sooryanarayana Varambally
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 18
Jiaoti Huang
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 13
Hayley C Whitaker
University College London
Career Start Year 1999
Number of shared co-authors 3
Ian G Mills
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 11
Phillip G Febbo
Illumina Inc.
Career Start Year 1997
Number of shared co-authors 11
Matthew B Rettig
David Geffen School of Medicine, University of California los angeles
Career Start Year 1995
Number of shared co-authors 18
Bhaskar Kallakury
Georgetown University
Career Start Year 1993
Number of shared co-authors 1
Peter S Nelson
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 34
Rosina T Lis
National Cancer Institute
Career Start Year 1992
Number of shared co-authors 18
Guido Jenster
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 6
Gyorgy Petrovics
Henry Jackson Foundation for the Advancement of Military Medicine (HJF)
Career Start Year 1990
Number of shared co-authors 4
Christopher M Hovens
Royal Melbourne Hospital, The University of Melbourne
Career Start Year 1989
Number of shared co-authors 4
Adrie van Bokhoven
University of Colorado Anschutz Medical Campus
Career Start Year 1988
Number of shared co-authors 0
Francesco Caiazza
Department of Pharmaceutical Chemistry, University of California san francisco
Career Start Year 1987
Number of shared co-authors 0
Massimo Loda
Weill Medical College of Cornell University
Career Start Year 1984
Number of shared co-authors 39

Collaborators

Ashutosh K Tewari
Co-authored papers 15
Mark A Rubin
University of Bern
Co-authored papers 7
Francesca Demichelis
University of Trento
Co-authored papers 5
Olivier Elemento
Meyer Cancer Center
Co-authored papers 4
Andrea Sboner
Institute for Computational Biomedicine
Co-authored papers 4
Mark Gerstein
Yale University
Co-authored papers 3
Elai Davicioni
Veracyte Inc.
Co-authored papers 3
Himisha Beltran
Dana-Farber Cancer Institute
Co-authored papers 3
Lucas Lochovsky
Co-authored papers 2
David F Yankelevitz
Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Jacqueline Fontugne
Institut Curie, CNRS, PSL Research University
Co-authored papers 2
Brian D Brown
Co-authored papers 2
Juan Miguel Mosquera
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Myriam Kossai
INSERM, Universite Clermont Auvergne
Co-authored papers 2
Emma Guttman-Yassky
Co-authored papers 2
Zhengming Chen
Weill Cornell Medicine and New York Presbyterian Hospital
Co-authored papers 2
Naoki Kitabayashi
Co-authored papers 2
Alessandro Romanel
University of Trento
Co-authored papers 2
T David Soong
Janssen Pharmaceutical Research and Development
Co-authored papers 2
Samprit Banerjee
Weill Cornell Medical College, Cornell University
Co-authored papers 2
Miriam Merad
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Sacha Gnjatic
The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai
Co-authored papers 2
Matthew D Galsky
Co-authored papers 2
Theresa Y MacDonald
Caryl and Israel Englander Institute for Precision Medicine
Co-authored papers 2
Rakesh Kumar
Rutgers New Jersey Medical School
Co-authored papers 2
David S Rickman
Meyer Cancer Center
Co-authored papers 2
Kyung Park
New York University Langone Health
Co-authored papers 2
Ganesh V Raj
University of Texas Southwestern Medical Center at Dallas
Co-authored papers 2
Wasay M Hussain
Co-authored papers 1
Tim H-M Huang
University of Texas Health San Antonio (UTHSA)
Co-authored papers 1
Release 1.2